Metraipolis › archive › dc_cb79ee113c01
Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis — Europe PMC PMID:36852153
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36852153
- DOI
- 10.1002/jgh3.12856
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T21:54:23.631Z
- SHA-256 of the archived text
1a57ca584871d0d5d4746d59fd0a0ef85d824732a0ef65752ed197748a925d05- Stable URL of this page
https://metraipolis.com/documento/dc_cb79ee113c01
How to cite
Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis — Europe PMC PMID:36852153 — Europe PMC (en), https://europepmc.org/article/MED/36852153 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb79ee113c01 (Metraipolis archive dc_cb79ee113c01, sha256 1a57ca584871d0d5d4746d59fd0a0ef85d824732a0ef65752ed197748a925d05)
BibTeX
@misc{dccb79ee113c01,
title = {Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis — Europe PMC PMID:36852153},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36852153},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb79ee113c01; sha256 1a57ca584871d0d5d4746d59fd0a0ef85d824732a0ef65752ed197748a925d05},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36852153. Agents can read the archived copy with the MCP tool read_document.